Pro Medicus Signs $40M in 5-Year Renewals, Adding Cardiology Module to MedStar Deal
Pro Medicus Limited’s U.S. subsidiary has locked in two significant 5-year contract renewals worth a combined minimum of A$40 million, reinforcing its position in the competitive medical imaging market.
- A$31 million 5-year renewal with MedStar Health including new Cardiology module
- A$9 million 5-year renewal with Zwanger-Pesiri for Visage 7 Viewer
- Both contracts feature increased per transaction fees
- Renewals reflect confidence in Pro Medicus’ cloud-native imaging platform
- Transaction-based contracts offer potential upside beyond minimum values
Renewing Strategic Partnerships in US Healthcare
Pro Medicus Limited [ASX: PME], a leader in healthcare informatics, has announced two major contract renewals through its U.S. subsidiary, Visage Imaging, Inc. These agreements, spanning five years and valued at a combined minimum of A$40 million, underscore the company’s growing footprint in the American medical imaging sector.
The standout renewal is with MedStar Health, the largest health system in the Maryland and Washington, D.C. region. This A$31 million contract not only extends the use of the full Visage 7 suite, including Viewer, Open Archive, and Worklist modules, but also introduces the new Visage 7 Cardiology Imaging module. This addition highlights Pro Medicus’ commitment to expanding its product capabilities within existing client networks.
Cloud-Native Solutions Driving Growth
MedStar was notably Pro Medicus’ first fully cloud-deployed customer, and its growth since initial deployment has been substantial. CEO Dr Sam Hupert emphasised that the renewal and product expansion validate the company’s position as a provider of a scalable, enterprise-grade imaging solution that is fully cloud native. This cloud-first approach is increasingly critical as healthcare providers seek flexible, efficient, and secure imaging platforms.
Alongside MedStar, Pro Medicus also secured a five-year renewal with Zwanger-Pesiri, a prominent private outpatient radiology provider based in Long Island. Valued at A$9 million, this contract renewal marks the third term for Zwanger-Pesiri, reflecting a decade-long partnership. Dr Hupert highlighted the strong return on investment the Visage 7 platform offers, both financially and clinically, which has cemented the company’s role in supporting Zwanger-Pesiri’s growth.
Financial Structure and Market Implications
Both contracts are transaction-based, with fees negotiated higher than previous terms, signalling confidence in the platform’s value and usage growth. While the minimum contract values are clear, the transaction-based nature allows for potential upside, depending on the volume of imaging transactions processed. This structure aligns Pro Medicus’ revenue more closely with client activity, offering scalability and growth potential.
These renewals not only provide revenue visibility over the medium term but also reinforce Pro Medicus’ competitive positioning in the U.S. market, which remains a critical growth region for the company. The continued adoption of cloud-native solutions and the expansion into cardiology imaging suggest a strategic focus on broadening clinical applications and deepening client relationships.
Bottom Line?
With these substantial renewals, Pro Medicus sets the stage for sustained growth, but investors will watch closely for transaction volumes to unlock full contract potential.
Questions in the middle?
- How will transaction volumes evolve under the new contracts, and what upside might this generate?
- What are the prospects for further expansion of Visage 7 modules within existing and new clients?
- How will Pro Medicus maintain its competitive edge amid increasing cloud-native imaging solutions in the US market?
